All had severe right ventricular hypoplasia. Ten of the SVP pts (59%) were diagnosed with RVDCC (3 with ostial atresia), and 7 (41%) with non-RVDCC (5 with normal coronary anatomy and 2 with stenosis of one coronary artery). Sinusoids were present in all RVDCC and in 4 out of 7 non-RVDCC pts. Median follow up time was 8.2 years (0 months to 11.3 years). One patient in each group was lost to follow up. Five RVDCC pts died and 1 underwent transplant due to ischemia in the first 6 months of life. Four of the deaths, including the 3 pts with ostial atresia, occurred before discharge from first hospitalization. No deaths occurred after second stage palliation. Three of the 4 surviving RVDCC pts having undergone Fontan, although 2 demonstrated signs of cardiac ischemia (one by PET scan and another by ischemic cardiac arrest during diagnostic catheterization). No deaths or ischemic events occurred in non-RVDCC pts, 5 of whom have undergone completion of Fontan. Kaplan-Meier analysis demonstrated significantly better survival in non-RVDCC vs RVDCC pts (p=0.013). Conclusions: In pts with PA/IVS undergoing SVP, RVDCC is associated with high early in-hospital mortality. There should be early evaluation for cardiac transplant in pts with RVDCC. Mechanical circulatory support, as a bridge to transplant, should be considered in pts with signs of ischemia and heart failure. Non-RVDCC pts, including those with stenosis of a single coronary artery, have excellent long-term outcome in this series.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.